FY-504

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFY-504
Drug Alias NameNaV1.8 antagonists (YD Life science/Hanyang University/Hallym University)FY-504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHallym University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYD Life Science IncHanyang UniversityHallym University
Active IndicationsN/A
Inactive IndicationsPeripheral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A